pharmaphorum: From genetic insight to Phase 3: What rare neurology requires from R&D and capital From genetic insight to Phase 3: What rare neurology requires from R&D and capital FiercePharma: Pharma's reputation among neurology patient groups rises again, but big names drop off leaderboard The rapid transformation in patient perceptions of neurology drug developers continued in 2022, when the proportion of groups with positive views of the industry rose (PDF) for the third year on the ... Pharma's reputation among neurology patient groups rises again, but big names drop off leaderboard Rare neurology is entering a pivotal moment. Scientific understanding is accelerating, new technologies are maturing, and the patient need remains profoundly unmet.
As the biopharmaceutical community ... The practice of neurology is often misunderstood by practitioners in other fields, possibly because it can be mysterious to the point of inaccessibility. That's what makes the art of neurology ... Onco-neurology is an emerging multi-disciplinary sub-specialty dedicated to the study of the indirect effects of tumors and their therapeutic processes on the nervous system.
the neurology, Its core lies in ... The leading figure in the field of neurology has published Take Care of Your Brain Health, a guide to aging without cognitive decline. UAB neurology residents work in collaboration with various services in a team based approach. UAB neurology patient and family-centered care is centered on close collaboration with neurosurgery, ... Efforts to improve diversity, equity and inclusion (DEI) in the neurology community and in neurological care are central to addressing health disparities and thereby improving global brain health.
